Search Results 541-550 of 18342 for Lactation

1. An Extension Study to Evaluate the Long-Term Safety and Tolerability of NEOD001 for Treatment of People with Light Chain Amyloidosis - Mayo Clinic

   Women who are lactating. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the most up-to-date information ...

2. A Study Investigating Long-term Treatment With Spesolimab in People With a Skin Disease Called Hidradenitis Suppurativa Who Completed a Previous Clinical Trial

   ... lactating -Current pregnancy -Subjects for whom the specimen margins have been destroyed, damaged, or are otherwise not intact prior to imaging (device arm ...

3. A Study to Evaluate the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 Alone and Combined with Chemotherapy or Tislelizumab to Treat Patients with Metastatic Solid Tumors - Mayo Clinic

   Pregnant and/or lactating females. Receiving any other investigational agents or participating in any other clinical trial involving another investigational ...

4. Density MATTERS [Molecular Breast Imaging (MBI) And Tomosynthesis To Eliminate the Reservoir] - Mayo Clinic

   Participation eligibility · Patient is currently pregnant or plans to become pregnant during the course of the study. · Patient is currently lactating. · Patient ...

5. Study of SBP-101 in Pancreatic Cancer - Clinical Trials

   Pregnant or lactating; Major surgery within 4 weeks of the start of study treatment, without complete recovery; Participation in any other clinical ...

6. Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil - Mayo Clinic

   The patient is pregnant or lactating. The patient has any musculoskeletal disease or any other disease that would limit ambulation. The patient has ...

7. Effect of TAK-954 on Gastrointestinal and Colonic Transit in Diabetic or Idiopathic Gastroparesis Participants - Mayo Clinic

   If female, are pregnant or lactating or intending to become pregnant before participating in this study, during the study, and 4 to 5 days (5 half-lives) ...

8. Lenalidomide and AT-101 in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia - Mayo Clinic

   Pregnant or lactating females; Any condition, including the presence of laboratory abnormalities, which places the subject at unacceptable risk if he/she ...

9. Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer - Mayo Clinic

   Pregnant or lactating women; Insulin-dependent diabetes; patients with type II diabetes must meet the inclusion criteria outlined above; Uncontrolled ...

10. A Phase 2 Study Of PRM-151 In Subjects With Myelofibrosis - Mayo Clinic

    Women who are pregnant or lactating. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the most up-to-date ...